Morgan Stanley Call 210 TGT 16.01.../ DE000ME9SPM5 /
2024-06-10 11:57:09 AM | Chg.-0.030 | Bid12:04:40 PM | Ask12:04:40 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.480EUR | -5.88% | 0.480 Bid Size: 1,000 |
0.510 Ask Size: 1,000 |
Target Corp | 210.00 USD | 2026-01-16 | Call |
GlobeNewswire
12:33 PM
SMG INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that The Scotts Miracle-Gro Compan...
GlobeNewswire
12:30 PM
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operatio...
GlobeNewswire
12:30 PM
K92 Mining Announces Second Set of Drill Results From Maiden Program at Arakompa; Significant Strike...
GlobeNewswire
12:00 PM
VERASTEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Verastem, Inc. on Behalf of Verastem St...
GlobeNewswire
12:00 PM
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Secon...
GlobeNewswire
12:00 PM
Pulsar Announces Further Analysis Putting Topaz in the Top Tier of Global Primary Helium Projects
GlobeNewswire
11:00 AM
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire
11:00 AM
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire
11:00 AM
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
10:00 AM
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
GlobeNewswire
10:00 AM
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moder...